Hypoxia degradable AIE photosensitizer with high efficiency of photodynamic therapy and improved biological safety
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. Cancer treatment and survivorship statistics10.3322/caac.21565 ↗
2. A history of exploring cancer in context10.1038/s41568-018-0006-7 ↗
3. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
4. Boron dipyrromethene nano‐photosensitizers for anticancer phototherapies
5. AIE-based cancer theranostics10.1016/j.ccr.2019.213076 ↗
6. Advances in nanomaterials for photodynamic therapy applications: status and challenges10.1016/j.biomaterials.2020.119827 ↗
7. Innovative strategies for hypoxic-tumor photodynamic therapy10.1002/anie.201805138 ↗
8. Amino modified iodinated BODIPY photosensitizer for highly efficient NIR imaging-guided photodynamic therapy with ultralow dose10.1016/j.dyepig.2021.109611 ↗
9. Superoxide radical photogenerator with amplification effect: surmounting the achilles' heels of photodynamic oncotherapy10.1021/jacs.8b13141 ↗
10. A self‐degradable supramolecular photosensitizer with high photodynamic therapeutic efficiency and improved safety10.1002/ange.202012477 ↗
11. Multifunctional programmable DNA nanotrain for activatable hypoxia imaging and mitochondrion-targeted enhanced photodynamic therapy10.1021/acsami.0c21681 ↗
12. A cyclodextrin‐hosted Ir (III) complex for ratiometric mapping of tumor hypoxia in vivo10.1002/advs.202004044 ↗
13. Nitroreductase-activatable theranostic molecules with high PDT efficiency under mild hypoxia based on a TADF fluorescein derivative10.1021/acsami.9b04488 ↗
14. Selective colorimetric and fluorescence detection of nitroreductase enzymes in living cells10.1016/j.ijbiomac.2020.07.148 ↗
15. A fluorescent turn-on probe for nitroreductase imaging in living cells and tissues under hypoxia conditions10.1016/j.snb.2018.04.100 ↗
16. A mitochondria/lysosome-targeting fluorescence probe based on azonia-cyanine dye and its application in nitroreductase detection10.1016/j.snb.2019.127653 ↗
17. A cofactor‐substrate‐based supramolecular fluorescent probe for the ultrafast detection of nitroreductase under hypoxic conditions10.1002/ange.201915040 ↗
18. Recent progress in the design principles, sensing mechanisms, and applications of small-molecule probes for nitroreductases10.1016/j.ccr.2020.213460 ↗
19. Single‐molecule imaging of active mitochondrial nitroreductases using a photo‐crosslinking fluorescent sensor10.1002/anie.201904700 ↗
20. Near-infrared off-on fluorescence probe activated by NTR for in vivo hypoxia imaging10.1016/j.bios.2018.08.014 ↗
21. Hypoxia-activated NIR photosensitizer anchoring in the mitochondria for photodynamic therapy10.1039/C9SC03355F ↗
22. A nitroreductase-activatable near-infrared theranostic photosensitizer for photodynamic therapy under mild hypoxia10.1039/D0CC02019B ↗
23. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application10.1039/D0CS00173B ↗
24. Activatable fluorescent probe based on aggregation-induced emission for detecting hypoxia-related pathological conditions10.1016/j.aca.2020.05.046 ↗
25. Aggregation-induced emission of 1-methyl-1, 2, 3, 4, 5-pentaphenylsilole10.1039/b105159h ↗
26. Aggregation-induced emission (AIE): a historical perspective10.1002/anie.202007525 ↗
27. Aggregation‐induced emission: new vistas at the aggregate level10.1002/anie.201916729 ↗
28. Aggregation‐induced emission: recent advances in materials and biomedical applications10.1002/ange.202000845 ↗
29. Li H, Kim H, Han J, Nguyen V-N, Peng X, Yoon J. Activity-based smart AIEgens for detection, bioimaging, and therapeutics: recent progress and outlook. Aggregate 2(4):e51.10.1002/agt2.51 ↗
30. AIE luminogens as fluorescent bioprobes10.1016/j.trac.2019.115769 ↗
31. Organic luminescent materials: the concentration on aggregates from aggregation‐induced emission10.1002/agt2.2 ↗
32. Restriction of intramolecular motion (RIM): investigating AIE mechanism from experimental and theoretical studies10.1007/s40242-021-0381-6 ↗
33. Photosensitizers with aggregation‐induced emission: materials and biomedical applications10.1002/adma.201801350 ↗
34. Tuning organelle specificity and photodynamic therapy efficiency by molecular function design10.1021/acsnano.9b04430 ↗
35. Aggregation‐enhanced theranostics: AIE sparkles in biomedical field10.1002/agt2.7 ↗
36. Activity‐based NIR enzyme fluorescent probes for the diagnosis of tumors and image‐guided surgery10.1002/anie.202009796 ↗
37. Nanoaggregate probe for breast cancer metastasis through multispectral optoacoustic tomography and aggregation-induced NIR-I/II fluorescence imaging10.1002/anie.201913149 ↗
38. Side-chain engineering of aggregation-induced emission molecules for boosting cancer phototheranostics10.1002/adfm.202107545 ↗
39. Facile synthesis of AIEgens with wide color tunability for cellular imaging and therapy10.1039/C8SC05805A ↗
40. Good steel used in the blade: well-tailored Type-I photosensitizers with aggregation-induced emission characteristics for precise nuclear targeting photodynamic therapy10.1002/advs.202100524 ↗
41. BODIPY-based photodynamic agents for exclusively generating superoxide radical over singlet oxygen10.1002/anie.202106748 ↗
42. Triple-jump photodynamic theranostics: MnO2 combined upconversion nanoplatforms involving a Type-I photosensitizer with aggregation-induced emission characteristics for potent cancer treatment10.1002/adma.202103748 ↗
43. Self-monitoring the endo-Lysosomal escape and near-infrared-activated mitophagy to guide synergistic Type-I photodynamic and photothermal therapy10.1021/acs.analchem.1c02310 ↗
44. An open source and reduce expenditure ROS generation strategy for chemodynamic/photodynamic synergistic therapy10.1038/s41467-020-15591-4 ↗
45. A near-infrared bioprobe with aggregation-induced emission feature for in vitro photodynamic therapy10.1016/j.dyepig.2021.109521 ↗